Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
ELCC 2019
The 9th European Lung Cancer Conference
Geneva, Switzerland - 10 Apr - 13 Apr 2019
Presentation Date(s):- 10 Apr - 13 Apr 2019
- Total Presentations: 489
-
+
Bristol-Myers Squibb - Industry Satellite Symposium
- Type: Industry Satellite symposium
- Presentations: 6
- Coordinates: 4/10/2019, 18:15 - 19:15, Room A
-
+
Clinical practice today and future considerations
18:20 - 18:45 | Presenter: Solange Peters
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
Moderator
19:00 - 19:00 | Presenter: Solange Peters
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Immunotherapy in stage IV
- Type: Educational session
- Presentations: 6
- Coordinates: 4/11/2019, 09:00 - 10:30, Room B
-
+
I-O monotherapy
09:00 - 09:20 | Presenter: Martin Reck
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Lunch & Poster Display session
- Type: Poster Display session
- Presentations: 170
- Coordinates: 4/11/2019, 12:30 - 13:00, Hall 1
-
+
66P - Treatment (tx) characteristics and clinical outcomes in patients (pts) with extensive-stage small cell lung cancer (ES-SCLC) treated with carboplatin (carbo) or cisplatin (cis) in combination with etoposide (etop) in US clinical practice
12:30 - 12:30 | Presenter: Martin Sebastian
- Abstract
Loading... -
+
82TiP - IMpower030: Phase III study evaluating neoadjuvant treatment of resectable stage II-IIIB non-small cell lung cancer (NSCLC) with atezolizumab (atezo) + chemotherapy
12:30 - 12:30 | Presenter: Solange Peters
- Abstract
Loading... -
+
125P - Elderly patients treated with afatinib in clinical practice: Results from the prospective non-interventional study GIDEON
12:30 - 12:30 | Presenter: Wolfgang Brückl
- Abstract
Loading...
-
+
ESMO-IASLC Best Abstracts
- Type: Proffered Paper session
- Presentations: 7
- Coordinates: 4/11/2019, 14:45 - 16:15, Room B
-
+
LBA1_PR - Nivolumab (nivo) plus ipilimumab (ipi), nivo, or placebo (pbo) as maintenance therapy in patients (pts) with extensive disease small cell lung cancer (ED-SCLC) after first-line (1L) platinum-based chemotherapy (chemo): Results from the double-blind, randomized phase III CheckMate 451 study
14:45 - 15:00 | Presenter: Taofeek K Owonikoko
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
103O_PR - Safety and efficacy of pembrolizumab (Pembro) monotherapy in elderly patients (Pts) with PD-L1–positive advanced NSCLC: Pooled analysis from KEYNOTE-010, -024, and -042
15:45 - 16:00 | Presenter: Kaname Nosaki
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
Boehringer Ingelheim - Industry Satellite Symposium
- Type: Industry Satellite symposium
- Presentations: 6
- Coordinates: 4/11/2019, 18:00 - 19:00, Room A
-
+
Recent changes and sequencing strategies in non-mutated, non-squamous advanced NSCLC
18:30 - 18:45 | Presenter: Martin Reck
- Abstract
No abstract available for this presentation
-
+
Proffered Paper session III
- Type: Proffered Paper session
- Presentations: 8
- Coordinates: 4/12/2019, 08:30 - 10:00, Room A
-
+
104O - IMpower150: An exploratory analysis of efficacy outcomes in patients with EGFR mutations
08:42 - 08:54 | Presenter: Martin Reck
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.